“Ms Albarracin said that treating the retina with just a few minutes exposure to soft near-infra-red light a day for less than a week had produced a remarkable recovery in damaged photoreceptors (vision cells) which ordinarily would have died. “
The authors conclude that LLLT is a safe and beneficial approach, based on scientifically sound mechanisms of action of red to near-infrared light on cytochrome oxidase, with neurotherapeutic promise for a wide range of ophthalmological, neurological, and psychological conditions.
These ﬁndings have important implications for PBM as a potential adjunct therapy to inhibit DR and possibly other degenerative processes. It seems likely that PBM is having beneicial effects on the retina via multiple mechanisms.